Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Liping Yu

Concepts (257)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Autoantibodies
55
2026
1504
5.530
 Why?
Diabetes Mellitus, Type 1
59
2026
3903
3.580
 Why?
Luminescent Measurements
7
2021
76
2.830
 Why?
Celiac Disease
8
2023
309
2.190
 Why?
Islets of Langerhans
23
2026
839
2.090
 Why?
Glutamate Decarboxylase
15
2022
165
1.840
 Why?
Electrochemical Techniques
4
2021
55
1.670
 Why?
High-Throughput Screening Assays
3
2020
174
1.500
 Why?
Zinc Transporter 8
11
2026
70
1.380
 Why?
Autoimmune Diseases
5
2020
462
1.290
 Why?
Transglutaminases
6
2023
159
1.210
 Why?
Mass Screening
11
2021
1347
1.160
 Why?
Insulin Antibodies
10
2016
103
1.140
 Why?
Prediabetic State
6
2015
246
1.080
 Why?
Cation Transport Proteins
8
2013
118
1.050
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 8
6
2016
54
0.930
 Why?
Insulin
20
2021
2500
0.870
 Why?
Proinsulin
4
2016
51
0.860
 Why?
Sensitivity and Specificity
14
2022
1990
0.850
 Why?
Diagnostic Techniques, Endocrine
3
2019
14
0.650
 Why?
Autoantigens
7
2021
425
0.630
 Why?
Antibodies, Viral
2
2023
671
0.530
 Why?
Autoimmunity
12
2023
928
0.500
 Why?
Child, Preschool
25
2023
11767
0.450
 Why?
Child
33
2026
22562
0.440
 Why?
Biomarkers
7
2022
4248
0.410
 Why?
Glucose Intolerance
1
2015
142
0.400
 Why?
Adolescent
29
2026
22370
0.380
 Why?
Infant
19
2023
10011
0.380
 Why?
Humans
64
2026
144298
0.370
 Why?
Luminescence
4
2016
38
0.360
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
97
0.340
 Why?
Peptide Fragments
8
2016
691
0.310
 Why?
Male
31
2026
72263
0.300
 Why?
Young Adult
14
2026
14092
0.290
 Why?
Female
35
2026
78137
0.290
 Why?
Immunologic Factors
1
2011
258
0.290
 Why?
Protein Precursors
3
2021
135
0.290
 Why?
Diabetes Mellitus, Type 2
3
2022
2571
0.290
 Why?
Radioimmunoassay
4
2016
165
0.280
 Why?
Quality Improvement
1
2017
1287
0.280
 Why?
Radioligand Assay
2
2009
36
0.280
 Why?
Adult
19
2026
40408
0.270
 Why?
Antibodies, Antinuclear
1
2007
62
0.250
 Why?
Reagent Kits, Diagnostic
1
2007
34
0.250
 Why?
Disease Progression
9
2019
2844
0.230
 Why?
Risk Factors
10
2021
10783
0.230
 Why?
Nephrotic Syndrome
1
2026
44
0.230
 Why?
Seroepidemiologic Studies
3
2023
171
0.220
 Why?
Insulin-Secreting Cells
3
2019
388
0.220
 Why?
Podocytes
1
2026
80
0.220
 Why?
Addison Disease
3
2012
38
0.220
 Why?
Middle Aged
13
2026
35892
0.210
 Why?
Lupus Erythematosus, Systemic
1
2007
237
0.210
 Why?
CD4-Positive T-Lymphocytes
4
2021
1129
0.200
 Why?
Enzyme-Linked Immunosorbent Assay
5
2011
832
0.200
 Why?
Membrane Glycoproteins
1
2026
495
0.190
 Why?
Case-Control Studies
3
2021
3595
0.190
 Why?
Isoenzymes
2
2004
297
0.180
 Why?
Disease Susceptibility
2
2020
342
0.180
 Why?
Electrochemistry
1
2021
72
0.170
 Why?
Genotype
9
2016
1843
0.170
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2022
253
0.170
 Why?
China
1
2021
269
0.170
 Why?
Predictive Value of Tests
6
2015
2113
0.160
 Why?
Polymorphism, Genetic
4
2017
612
0.160
 Why?
DNA
1
2007
1444
0.160
 Why?
GTP-Binding Proteins
1
2021
153
0.160
 Why?
Spike Glycoprotein, Coronavirus
1
2021
130
0.150
 Why?
Steroid 21-Hydroxylase
3
2012
27
0.150
 Why?
Health Fairs
1
2019
10
0.150
 Why?
Follow-Up Studies
6
2021
5404
0.150
 Why?
Endothelial Cells
1
2026
862
0.150
 Why?
Risk Assessment
3
2020
3680
0.140
 Why?
Colorado
4
2023
4554
0.140
 Why?
Phosphoproteins
1
2021
335
0.140
 Why?
Prognosis
5
2021
4293
0.140
 Why?
Prevalence
3
2023
2836
0.140
 Why?
Epitopes
4
2021
479
0.140
 Why?
Receptors, Antigen, T-Cell
2
2023
667
0.130
 Why?
Polyendocrinopathies, Autoimmune
1
2017
18
0.130
 Why?
Antibody Specificity
4
2011
178
0.130
 Why?
Cohort Studies
3
2021
5948
0.130
 Why?
Population Surveillance
1
2020
483
0.130
 Why?
Mice, Inbred NOD
8
2008
608
0.120
 Why?
Disease Management
1
2020
647
0.120
 Why?
Health Care Costs
1
2020
425
0.120
 Why?
Age of Onset
4
2026
551
0.120
 Why?
T-Lymphocytes
5
2023
1981
0.120
 Why?
HLA-DQ Antigens
5
2016
173
0.120
 Why?
Aged
6
2026
25901
0.120
 Why?
Risk
2
2019
910
0.110
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
675
0.110
 Why?
Incidence
1
2021
2886
0.110
 Why?
Transcription Factors
2
2017
1726
0.100
 Why?
Protein Tyrosine Phosphatases
3
2004
167
0.100
 Why?
Poly I-C
2
2004
57
0.100
 Why?
Biopsy
1
2016
1078
0.100
 Why?
Reproducibility of Results
2
2019
3408
0.090
 Why?
Prospective Studies
6
2023
7972
0.090
 Why?
Histocompatibility Antigens Class I
3
2009
201
0.090
 Why?
HLA-DR Antigens
4
2016
220
0.090
 Why?
Iodine Radioisotopes
1
2011
137
0.080
 Why?
Pedigree
3
2017
512
0.080
 Why?
Mice
15
2026
18218
0.080
 Why?
Glucose Tolerance Test
1
2012
359
0.080
 Why?
Rituximab
1
2011
211
0.080
 Why?
HLA-DR4 Antigen
3
2011
74
0.080
 Why?
HLA-DR3 Antigen
3
2011
76
0.080
 Why?
Drug Administration Schedule
1
2011
779
0.070
 Why?
Animals
16
2026
37800
0.070
 Why?
Laboratories
1
2009
109
0.070
 Why?
Interferon-alpha
2
2009
194
0.070
 Why?
Longitudinal Studies
3
2021
2940
0.060
 Why?
Radioimmunoprecipitation Assay
1
2007
6
0.060
 Why?
Antibody Formation
1
2008
291
0.060
 Why?
Diagnosis, Differential
1
2011
1501
0.060
 Why?
Histocompatibility Antigens
1
2008
102
0.060
 Why?
Family
1
2012
678
0.060
 Why?
Peptides
2
2023
985
0.060
 Why?
Recombinant Fusion Proteins
1
2009
666
0.060
 Why?
Double-Blind Method
1
2011
2032
0.060
 Why?
Membrane Proteins
2
2004
1158
0.060
 Why?
CD4 Antigens
2
2003
137
0.060
 Why?
Integrin beta1
1
2026
33
0.060
 Why?
Proteinuria
1
2026
103
0.060
 Why?
C-Peptide
2
2016
189
0.060
 Why?
Receptors, Complement
1
2026
125
0.060
 Why?
Kidney Glomerulus
1
2026
127
0.060
 Why?
Transforming Growth Factor beta1
1
2026
176
0.050
 Why?
Anaphylaxis
2
2004
102
0.050
 Why?
Antibodies, Heterophile
1
2004
12
0.050
 Why?
Twins, Dizygotic
1
2004
109
0.050
 Why?
Models, Biological
1
2011
1807
0.050
 Why?
Mice, Knockout
3
2026
3106
0.050
 Why?
Mice, Inbred BALB C
5
2004
1246
0.050
 Why?
Siblings
1
2004
195
0.050
 Why?
Endocrine System Diseases
1
2004
35
0.050
 Why?
Immunity, Mucosal
1
2004
98
0.050
 Why?
Doxorubicin
1
2026
397
0.050
 Why?
Glycolipids
1
2004
52
0.050
 Why?
Remission Induction
1
2004
308
0.050
 Why?
Immunoglobulin E
2
2021
315
0.050
 Why?
Genetic Testing
1
2005
479
0.050
 Why?
Osteopontin
1
2022
34
0.050
 Why?
Fetal Blood
1
2004
325
0.040
 Why?
Epitopes, B-Lymphocyte
1
2021
20
0.040
 Why?
Diagnostic Techniques, Radioisotope
1
2021
9
0.040
 Why?
Seroconversion
1
2021
48
0.040
 Why?
Immunoglobulin D
1
2021
29
0.040
 Why?
Serologic Tests
1
2021
53
0.040
 Why?
Diabetes Mellitus, Experimental
1
2002
181
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2134
0.040
 Why?
Canada
1
2002
429
0.040
 Why?
Multicenter Studies as Topic
1
2002
408
0.040
 Why?
Asymptomatic Diseases
1
2021
103
0.040
 Why?
Immunoglobulin G
2
2021
886
0.040
 Why?
Quality-Adjusted Life Years
1
2020
122
0.040
 Why?
Immunoglobulin M
1
2021
280
0.040
 Why?
Blood Specimen Collection
1
2019
37
0.040
 Why?
Immunoglobulin A
1
2021
214
0.040
 Why?
Infant, Newborn
4
2005
6387
0.040
 Why?
Costs and Cost Analysis
1
2020
220
0.040
 Why?
Age Factors
2
2004
3324
0.040
 Why?
Early Diagnosis
1
2020
248
0.040
 Why?
Methylation
1
2019
241
0.040
 Why?
Adrenocorticotropic Hormone
2
2012
147
0.030
 Why?
Proportional Hazards Models
2
2016
1322
0.030
 Why?
Alleles
3
2009
881
0.030
 Why?
Tissue Donors
1
2021
412
0.030
 Why?
Loss of Function Mutation
1
2017
46
0.030
 Why?
Cell Death
1
2019
382
0.030
 Why?
Community Health Services
1
2019
231
0.030
 Why?
Diabetic Ketoacidosis
1
2020
209
0.030
 Why?
Cost-Benefit Analysis
1
2020
637
0.030
 Why?
Clinical Trials as Topic
1
2002
1055
0.030
 Why?
Hydrocortisone
2
2012
297
0.030
 Why?
Mice, Transgenic
3
2008
2177
0.030
 Why?
Phenotype
2
2021
3139
0.030
 Why?
HLA-DQ beta-Chains
2
2009
57
0.030
 Why?
Antibodies, Monoclonal
1
2003
1501
0.030
 Why?
Cross-Sectional Studies
2
2023
5862
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2008
749
0.030
 Why?
Time Factors
3
2016
7128
0.030
 Why?
Antibody Affinity
1
2016
60
0.030
 Why?
Protein Domains
1
2017
312
0.030
 Why?
Polymerase Chain Reaction
2
2009
1046
0.030
 Why?
Organ Specificity
2
2007
311
0.030
 Why?
Genome-Wide Association Study
1
2022
1373
0.030
 Why?
Proteomics
1
2022
1182
0.030
 Why?
Blood Glucose
3
2016
2326
0.030
 Why?
HEK293 Cells
1
2017
741
0.030
 Why?
Injections, Subcutaneous
2
2004
168
0.030
 Why?
Adoptive Transfer
2
2005
197
0.030
 Why?
Mice, SCID
2
2005
368
0.020
 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 1
2
2004
44
0.020
 Why?
Multivariate Analysis
1
2016
1537
0.020
 Why?
Renin
1
2012
32
0.020
 Why?
Spleen
2
2005
507
0.020
 Why?
Signal Transduction
1
2026
5182
0.020
 Why?
Administration, Oral
2
2004
847
0.020
 Why?
Immunization
2
2004
373
0.020
 Why?
Enzyme-Linked Immunospot Assay
1
2011
37
0.020
 Why?
Feasibility Studies
1
2015
1098
0.020
 Why?
Hypoglycemic Agents
1
2020
1388
0.020
 Why?
Graves Disease
1
2009
30
0.020
 Why?
Homozygote
1
2009
199
0.020
 Why?
HLA-DRB1 Chains
1
2009
109
0.020
 Why?
Microsatellite Repeats
1
2009
155
0.020
 Why?
International Cooperation
1
2009
197
0.020
 Why?
Retrospective Studies
1
2026
17104
0.020
 Why?
Interferon-gamma
1
2011
781
0.020
 Why?
Pediatrics
1
2015
1118
0.020
 Why?
ROC Curve
1
2009
615
0.020
 Why?
Age Distribution
1
2007
402
0.020
 Why?
Metabolic Networks and Pathways
1
2008
186
0.020
 Why?
Rats
2
2004
5553
0.010
 Why?
Thyroglobulin
1
2005
29
0.010
 Why?
Iodide Peroxidase
1
2005
35
0.010
 Why?
Integrin alpha Chains
1
2004
22
0.010
 Why?
Family Health
1
2005
191
0.010
 Why?
Histocompatibility Testing
1
2004
121
0.010
 Why?
B7-1 Antigen
1
2004
55
0.010
 Why?
False Positive Reactions
1
2004
122
0.010
 Why?
United States
1
2002
15979
0.010
 Why?
Endocrine System
1
2004
22
0.010
 Why?
HLA Antigens
1
2005
231
0.010
 Why?
Disease Models, Animal
2
2004
4525
0.010
 Why?
Single-Blind Method
1
2004
318
0.010
 Why?
Cyclophosphamide
1
2003
265
0.010
 Why?
T-Box Domain Proteins
1
2003
106
0.010
 Why?
Species Specificity
1
2004
572
0.010
 Why?
Enkephalins
1
2002
21
0.010
 Why?
Delivery, Obstetric
1
2004
161
0.010
 Why?
Pyridinium Compounds
1
2002
31
0.010
 Why?
Reference Values
1
2004
793
0.010
 Why?
CD8 Antigens
1
2002
70
0.010
 Why?
HLA-A Antigens
1
2002
52
0.010
 Why?
Mice, Inbred C57BL
2
2004
5954
0.010
 Why?
Models, Immunological
1
2002
100
0.010
 Why?
Gene Expression Profiling
1
2008
1762
0.010
 Why?
Chronic Disease
1
2008
1809
0.010
 Why?
Antigens, CD
1
2004
552
0.010
 Why?
Antibodies
1
2003
396
0.010
 Why?
Regression Analysis
1
2004
997
0.010
 Why?
Major Histocompatibility Complex
1
2002
229
0.010
 Why?
Glucagon
1
2002
114
0.010
 Why?
Cells, Cultured
1
2008
4102
0.010
 Why?
Histocompatibility Antigens Class II
1
2002
364
0.010
 Why?
Survival Analysis
1
2003
1368
0.010
 Why?
Amino Acid Sequence
1
2004
2127
0.010
 Why?
Genetic Predisposition to Disease
1
2008
2348
0.010
 Why?
Proteins
1
2004
1011
0.010
 Why?
Immunity, Innate
1
2004
842
0.010
 Why?
Immunohistochemistry
1
2002
1699
0.010
 Why?
Vaccination
1
2003
1416
0.010
 Why?
Pregnancy
1
2004
7112
0.010
 Why?
Yu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (257) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)